Hyderabad: Telangana continued to get a good deal for the allocation of important medical sources wanted to deal with Covid optimistic sufferers.
The middle on Friday improved the allocation of Remdesivir to a number of states and in comparison with Gujarat, Uttar Pradesh, Tamil Nadu and Karnataka, Telangana didn’t obtain its justifiable share of the antiviral drug.
The middle awarded 41,800 doses of Remdesivir to Telangana on Friday, which might final barely a week, senior public well being officers stated. Discrimination towards Telangana over the distribution of Remdesivir medication got here to the fore as the middle selected to extend the doses from 21,500 to 41,800, a rise of solely 20,000 doses for a interval of ten days.
Gujarat with an lively case load of 1,37,794 Covid instances obtained a whopping 1.82 500 doses of Remdesivir. Similarly, with 98,000 lively instances, New Delhi obtained roughly 81,300 Remdesivir injections, whereas Tamil Nadu obtained 67,500 Remdesivir injections with 1,12,556 lively infections. In stark distinction, Telangana with an lively payload of just about 80,000 Covid sufferers got solely 41,800 doses of Remdesivir.
The middle has had full management over the provision of Remdesivir, oxygen and vaccinations for the previous few weeks, however has constantly failed to make sure a honest and regular distribution of important sources. Covid sufferers in Telangana.
Public well being officers in the state stated they had been pressured to make use of a ‘triage system’ as a result of restricted availability of Remdesivir, which suggests they had been pressured to distribute Remdesivir as a result of urgency or medical situation of the affected person .
“In anticipation of these problems, Prime Minister K Chandrashekhar Rao and IT Minister KT Rama Rao have held detailed discussions with pharmaceutical manufacturers in Hyderabad on the production and sale of Remdesivir. Telangana was one of the first states to place an order for nearly 5 lakh doses of Remdesivir, which should have been enough to see us through the whole pandemic. The decision of the center to regulate the availability of Remdesivir affects all the states, ”stated senior docs accustomed to the problem.
Source: Telangana Today